{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:36:48Z","timestamp":1778895408157,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Third-Term Comprehensive 10-Year Strategy for Cancer Control","award":["13801892"],"award-info":[{"award-number":["13801892"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.lungcan.2015.01.027","type":"journal-article","created":{"date-parts":[[2015,2,7]],"date-time":"2015-02-07T18:15:31Z","timestamp":1423332931000},"page":"16-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Chronic nicotine exposure mediates resistance to EGFR-TKI in EGFR -mutated lung cancer via an EGFR signal"],"prefix":"10.1016","volume":"88","author":[{"given":"Yosuke","family":"Togashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunio","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichi","family":"Fumita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Terashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco A.","family":"de Velasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuko","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuta","family":"Tomida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuto","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lungcan.2015.01.027_bib0200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.lungcan.2015.01.027_bib0205","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3322\/caac.21149","article-title":"Cancer treatment and survivorship statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"10.1016\/j.lungcan.2015.01.027_bib0210","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nrc2947","article-title":"Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer","volume":"10","author":"Pao","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2015.01.027_bib0215","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1470-2045(10)70087-5","article-title":"New driver mutations in non-small-cell lung cancer","volume":"12","author":"Pao","year":"2011","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.lungcan.2015.01.027_bib0220","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin\u2013paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"Mok","year":"2009","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.lungcan.2015.01.027_bib0225","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1470-2045(09)70364-X","article-title":"Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial","volume":"11","author":"Mitsudomi","year":"2010","journal-title":"Lancet Oncol"},{"issue":"25","key":"10.1016\/j.lungcan.2015.01.027_bib0230","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","article-title":"Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR","volume":"362","author":"Maemondo","year":"2010","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.lungcan.2015.01.027_bib0235","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1470-2045(11)70184-X","article-title":"Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study","volume":"12","author":"Zhou","year":"2011","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.lungcan.2015.01.027_bib0240","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","article-title":"Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial","volume":"13","author":"Rosell","year":"2012","journal-title":"Lancet Oncol"},{"issue":"27","key":"10.1016\/j.lungcan.2015.01.027_bib0245","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1200\/JCO.2012.44.2806","article-title":"Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations","volume":"31","author":"Sequist","year":"2013","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.lungcan.2015.01.027_bib0250","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1200\/JCO.2009.24.7049","article-title":"Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer","volume":"28","author":"Jackman","year":"2010","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.lungcan.2015.01.027_bib0255","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1056\/NEJMoa044238","article-title":"EGFR mutation and resistance of non-small-cell lung cancer to gefitinib","volume":"352","author":"Kobayashi","year":"2005","journal-title":"N Engl J Med"},{"issue":"3\u20134","key":"10.1016\/j.lungcan.2015.01.027_bib0260","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10555-012-9391-7","article-title":"Acquired resistance mechanisms to tyrosine kinase inhibitors in lung cancer with activating epidermal growth factor receptor mutation\u2014diversity, ductility, and destiny","volume":"31","author":"Suda","year":"2012","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"10.1016\/j.lungcan.2015.01.027_bib0265","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ctrv.2013.06.002","article-title":"Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: a new era begins","volume":"40","author":"Remon","year":"2014","journal-title":"Cancer Treat Rev"},{"issue":"1\u20132","key":"10.1016\/j.lungcan.2015.01.027_bib0270","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0304-3835(88)90251-0","article-title":"A study of tobacco carcinogenesis. XLII. Bioassay in A\/J mice of some structural analogues of tobacco-specific nitrosamines","volume":"42","author":"Hecht","year":"1988","journal-title":"Cancer Lett"},{"issue":"8","key":"10.1016\/j.lungcan.2015.01.027_bib0275","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1470-2045(02)00815-X","article-title":"Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention","volume":"3","author":"Hecht","year":"2002","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.lungcan.2015.01.027_bib0280","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1172\/JCI28164","article-title":"Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways","volume":"116","author":"Dasgupta","year":"2006","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.lungcan.2015.01.027_bib0285","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ijc.23894","article-title":"Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines","volume":"124","author":"Dasgupta","year":"2009","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.lungcan.2015.01.027_bib0290","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/89961","article-title":"Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis","volume":"7","author":"Heeschen","year":"2001","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.lungcan.2015.01.027_bib0295","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1158\/1535-7163.MCT-12-1029","article-title":"Src mediates cigarette smoke-induced resistance to tyrosine kinase inhibitors in NSCLC cells","volume":"12","author":"Filosto","year":"2013","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"10.1016\/j.lungcan.2015.01.027_bib0300","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1158\/1535-7163.MCT-11-0698","article-title":"Cigarette smoke induces aberrant EGF receptor activation that mediates lung cancer development and resistance to tyrosine kinase inhibitors","volume":"11","author":"Filosto","year":"2012","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"10.1016\/j.lungcan.2015.01.027_bib0305","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/JTO.0b013e31828b51d4","article-title":"Nicotine induces resistance to epidermal growth factor receptor tyrosine kinase inhibitor by (1 nicotinic acetylcholine receptor-mediated activation in PC9 cells","volume":"8","author":"Wang","year":"2013","journal-title":"J Thorac Oncol"},{"issue":"24","key":"10.1016\/j.lungcan.2015.01.027_bib0310","doi-asserted-by":"crossref","first-page":"9101","DOI":"10.1158\/0008-5472.CAN-04-2360","article-title":"Small in-frame deletion in the epidermal growth factor receptor as a target for ZD6474","volume":"64","author":"Arao","year":"2004","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.lungcan.2015.01.027_bib0315","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1158\/0008-5472.CAN-09-2161","article-title":"FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth","volume":"70","author":"Kaneda","year":"2010","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.lungcan.2015.01.027_bib0320","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1158\/0008-5472.CAN-06-4628","article-title":"Expression of nicotinic acetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers","volume":"67","author":"Lam","year":"2007","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.lungcan.2015.01.027_bib0325","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.pupt.2006.07.001","article-title":"Nicotine activates cell-signaling pathways through muscle-type and neuronal nicotinic acetylcholine receptors in non-small cell lung cancer cells","volume":"20","author":"Carlisle","year":"2007","journal-title":"Pulm Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.lungcan.2015.01.027_bib0330","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1158\/1078-0432.CCR-10-2434","article-title":"Nicotinic acetylcholine receptor-based blockade: applications of molecular targets for cancer therapy","volume":"17","author":"Wu","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.lungcan.2015.01.027_bib0335","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/jnci\/dji055","article-title":"Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers","volume":"97","author":"Shigematsu","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"21","key":"10.1016\/j.lungcan.2015.01.027_bib0340","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1200\/JCO.2010.33.4235","article-title":"Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin\/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS)","volume":"29","author":"Fukuoka","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2015.01.027_bib0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2014.06.011","article-title":"Impact of smoking status on EGFR-TKI efficacy for advanced non-small-cell lung cancer in EGFR mutants: a meta-analysis","author":"Zhang","year":"2014","journal-title":"Clin Lung Cancer"},{"issue":"12","key":"10.1016\/j.lungcan.2015.01.027_bib0350","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/j.1349-7006.2007.00607.x","article-title":"Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer","volume":"98","author":"Mitsudomi","year":"2007","journal-title":"Cancer Sci"},{"issue":"10","key":"10.1016\/j.lungcan.2015.01.027_bib0355","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/jclinpath-2012-201296","article-title":"Lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy?","volume":"66","author":"Ou","year":"2013","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1016\/j.lungcan.2015.01.027_bib0360","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/cncr.27824","article-title":"Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohort","volume":"119","author":"Ferketich","year":"2013","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.lungcan.2015.01.027_bib0365","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/annonc\/mdg250","article-title":"Phase I pharmacokinetic trial of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (\u2019Iressa\u2019, ZD1839) in Japanese patients with solid malignant tumors","volume":"14","author":"Nakagawa","year":"2003","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.lungcan.2015.01.027_bib0370","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00280-007-0494-8","article-title":"Phase I dose-finding and pharmacokinetic study of the oral epidermal growth factor receptor tyrosine kinase inhibitor Ro50-8231 (erlotinib) in Japanese patients with solid tumors","volume":"61","author":"Yamamoto","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4 (Suppl. 1)","key":"10.1016\/j.lungcan.2015.01.027_bib0375","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2008.01.015","article-title":"Neurobiology of nicotine addiction: implications for smoking cessation treatment","volume":"121","author":"Benowitz N.L.","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.lungcan.2015.01.027_bib0380","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev-neuro-061010-113734","article-title":"addiction, withdrawal to nicotine","volume":"34","author":"De Biasi","year":"2011","journal-title":"Annu Rev Neurosci"},{"issue":"3","key":"10.1016\/j.lungcan.2015.01.027_bib0385","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tips.2007.12.006","article-title":"Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis","volume":"29","author":"Egleton","year":"2008","journal-title":"Trends Pharmacol Sci"},{"issue":"13","key":"10.1016\/j.lungcan.2015.01.027_bib0390","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1158\/1078-0432.CCR-09-0391","article-title":"Combined survival analysis of prospective clinical trials of gefitinib for non-small cell lung cancer with EGFR mutations","volume":"15","author":"Morita","year":"2009","journal-title":"Clin Cancer Res"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500215000926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500215000926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T11:24:37Z","timestamp":1537874677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500215000926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0169500215000926"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2015.01.027","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic nicotine exposure mediates resistance to EGFR-TKI in EGFR-mutated lung cancer via an EGFR signal","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2015.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}